EUVIMEDEUVIMED entdecken
Open Access

Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening

Marissa B Lawson iD, Savannah C Partridge iD, Daniel S Hippe iD, Habib Rahbar iD, Diana L Lam iD, Christoph I Lee, Kathryn P Lowry iD, John R Scheel iD, Sana Parsian iD, Isabella Li iD, Debosmita Biswas iD, Mary Lynn Bryant und 1 weitere

Radiology · 2023

DOI: 10.1148/radiol.230576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology, 2023. Verfasst von Marissa B Lawson und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology, University of Washington, Seattle, Wash (M.B.L., S.C.P., H.R., D.L.L., C.I.L., K.P.L., I.L., D.B., M.L.B., J.M.L.);…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, GE Healthcare, National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contrast-enhanced mammography (CEM) and abbreviated breast MRI (ABMRI) are emerging alternatives to standard MRI for supplemental breast cancer screening.

Purpose

To compare the diagnostic performance of CEM, ABMRI, and standard MRI. Materials and Methods This single-institution, prospective, blinded reader study included female participants referred for breast MRI from January 2018 to June 2021. CEM was performed within 14 days of standard MRI; ABMRI was produced from standard MRI images. Two readers independently interpreted each CEM and ABMRI after a washout period. Examination-level performance metrics calculated were recall rate, cancer detection, and false-positive biopsy recommendation rates per 1000 examinations and sensitivity, specificity, and positive predictive value of biopsy recommendation. Bootstrap and permutation tests were used to calculate 95% CIs and compare modalities.

Results

Evaluated were 492 paired CEM and ABMRI interpretations from 246 participants (median age, 51 years; IQR, 43-61 years). On 49 MRI scans with lesions recommended for biopsy, nine lesions showed malignant pathology. No differences in ABMRI and standard MRI performance were identified. Compared with standard MRI, CEM demonstrated significantly lower recall rate (14.0% vs 22.8%; difference, -8.7%; 95% CI: -14.0, -3.5), lower false-positive biopsy recommendation rate per 1000 examinations (65.0 vs 162.6; difference, -97.6; 95% CI: -146.3, -50.8), and higher specificity (87.8% vs 80.2%; difference, 7.6%; 95% CI: 2.3, 13.1). Compared with standard MRI, CEM had significantly lower cancer detection rate (22.4 vs 36.6; difference, -14.2; 95% CI: -28.5, -2.0) and sensitivity (61.1% vs 100%; difference, -38.9%; 95% CI: -66.7, -12.5). The performance differences between CEM and ABMRI were similar to those observed between CEM and standard MRI.

Conclusion

ABMRI had comparable performance to standard MRI and may support more efficient MRI screening. CEM had lower recall and higher specificity compared with standard MRI or ABMRI, offset by lower cancer detection rate and sensitivity compared with standard MRI. These trade-offs warrant further consideration of patient population characteristics before widespread screening with CEM. Clinical trial registration no. NCT03517813 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Chang in this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansMiddle AgedProspective StudiesSensitivity and SpecificityEarly Detection of CancerMammographyMagnetic Resonance Imaging

Autor:innen und Institutionen

  • From the Department of Radiology, University of Washington, Seattle, Wash (M.B.L., S.C.P., H.R., D.L.L., C.I.L., K.P.L., I.L., D.B., M.L.B., J.M.L.); Department of Radiology (M.B.L., S.C.P., H.R., D.L.L., C.I.L., K.P.L.…

ORCID-Profile: Marissa B Lawson, Savannah C Partridge, Daniel S Hippe, Habib Rahbar, Diana L Lam, Kathryn P Lowry, John R Scheel, Sana Parsian, Isabella Li, Debosmita Biswas, Janie M Lee

Förderung

  • NCI NIH HHS
  • GE Healthcare
  • National Institutes of Health/National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Lawson, M. B., Partridge, S. C., Hippe, D. S., Rahbar, H., Lam, D. L., Lee, C. I., Lowry, K. P., Scheel, J. R., Parsian, S., Li, I., Biswas, D., Bryant, M. L., & Lee, J. M. (2023). Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening. Radiology. https://doi.org/10.1148/radiol.230576

Vancouver

Lawson MB, Partridge SC, Hippe DS, Rahbar H, Lam DL, Lee CI, et al. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening. Radiology. 2023. doi:10.1148/radiol.230576

BibTeX
@article{Lawson2023,
  author = {Lawson, Marissa B and Partridge, Savannah C and Hippe, Daniel S and Rahbar, Habib and Lam, Diana L and Lee, Christoph I and Lowry, Kathryn P and Scheel, John R and Parsian, Sana and Li, Isabella and Biswas, Debosmita and Bryant, Mary Lynn and Lee, Janie M},
  title = {Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening},
  journal = {Radiology},
  year = {2023},
  doi = {10.1148/radiol.230576}
}
Kostenlos starten →